These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 17414585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of losartan plus hydrochlorothiazide on nitric oxide status in 'nondipper' hypertensive patients.
    Cammarata R, Armas-Hernández MJ, Hernández-Hernández R, Armas-Padilla MC, Sosa-Canache B, Pacheco B, Guerrero J, Israili ZH, Valasco M.
    Am J Ther; 2007; 14(2):161-5. PubMed ID: 17414584
    [Abstract] [Full Text] [Related]

  • 3. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hürlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Lüscher TF, Noll G, Lehmann R.
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [Abstract] [Full Text] [Related]

  • 4. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D, Koç M, Toprak A, Akpinar I, Velioğlu A, Deyneli O, Haklar G, Akalin S.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide and malondialdehyde in human hypertension.
    Armas-Padilla MC, Armas-Hernández MJ, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero J, Carvajal AR, Hernández-Hernández R, Israili ZH, Valasco M.
    Am J Ther; 2007 Sep; 14(2):172-6. PubMed ID: 17414586
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
    Joshi SR, Yeolekar ME, Tripathi KK, Giri J, Maity AK, Chopda M, Gujarathi S, Maroli S, Maity A, LORD Trial.
    J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
    [Abstract] [Full Text] [Related]

  • 7. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein.
    Abdel-Zaher AO, Elkoussi AE, Abudahab LH, Elbakry MH, Elsayed EA.
    Fundam Clin Pharmacol; 2014 Jun; 28(3):237-48. PubMed ID: 23488690
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
    Nashar K, Nguyen JP, Jesri A, Morrow JD, Egan BM.
    Am J Hypertens; 2004 Jun; 17(6):477-82. PubMed ID: 15177518
    [Abstract] [Full Text] [Related]

  • 12. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
    Nikas S, Rizos E, Milionis H, Bairaktari E, Kalaitzidis R, Siamopoulos K, Elisaf M.
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
    [Abstract] [Full Text] [Related]

  • 13. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A, Basavanagowdappa H, Zawar S, Kumar A, Chandurkar N.
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [Abstract] [Full Text] [Related]

  • 14. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J, Ceypová K, Kristenová P, Hauser T.
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [Abstract] [Full Text] [Related]

  • 15. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [Abstract] [Full Text] [Related]

  • 16. Can losartan improve cardiac performance during the treadmill exercise test in hypertensive subjects?
    Paterna S, Parrinello G, Amato P, Bologna P, Fornaciari E, Follone G, Di Pasquale P, Di Marco A, Tarantino AM, Ducato G, Accardo Palumbo V, Colomba D, Sciortino A, Bascone F, Licata G.
    Drugs Exp Clin Res; 2002 Dec; 28(4):155-9. PubMed ID: 12512233
    [Abstract] [Full Text] [Related]

  • 17. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 18. Influence of losartan and atenolol on memory function in very elderly hypertensive patients.
    Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E, Preti P.
    J Hum Hypertens; 2003 Nov; 17(11):781-5. PubMed ID: 14578918
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H, Fujita T, Ito S, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N.
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [Abstract] [Full Text] [Related]

  • 20. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M, Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini L.
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.